drugset / Trial / NCT05566639

A Study of mRNA-1010 Seasonal Influenza Vaccine in Adults 50 Years Old and Older

NCT05566639

Phase 3 Completed 22502 enrolled ModernaTX, Inc.
RandomizedParallel-groupTriple-blindPrevention

Summary

The purpose of this study is to evaluate the safety and efficacy of mRNA-1010 in preventing seasonal influenza in adults 50 years and older.

Timeline

Start
2022-09-14
Primary completion
2024-01-05
Completion
2024-01-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fluarix Quadrivalent Vaccine Intramuscular
Subject Quadrivalent influenza vaccine Vaccine Intramuscular

Indications